S100B Is an important outcome predictor in traumatic brain injury

Journal of Neurotrauma

Volumn 30, Issue 7, 2013, Pages 519-528

  Thelin, Eric Peter ^a   Johannesson, Louise ^b   Nelson, David ^a   Bellander, Bo Michael ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

biomarkers; humans; outcome; S100B; TBI

Indexed keywords

PROTEIN S100B;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLASGOW COMA SCALE; GROUPS BY AGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PUPIL REFLEX; RETROSPECTIVE STUDY; SWEDEN; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOLOGICAL MARKERS; BRAIN INJURIES; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; ROC CURVE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; YOUNG ADULT;

EID: 84876939368     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2012.2553     Document Type: Article

References (76)

1. Jennett, B. (1996). Epidemiology of head injury. J. Neurol. Neurosurg. Psychiatry 60, 362-369.
2. Steyerberg, E.W., Mushkudiani, N., Perel, P., Butcher, I., Lu, J., McHugh, G.S. Murray, G.D., Marmarou, A., Roberts, I., Habbema, J.D., and Maas, A.I. (2008). Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 5, e165.
3. Tagliaferri, F., Compagnone, C., Korsic, M., Servadei, F., and Kraus, J. (2006). A systematic review of brain injury epidemiology in Europe. Acta Neurochir, (Wien) 148, 255-268.
4. Corrigan, J.D., Selassie, A.W., and Orman, J.A. (2010). The epidemiology of traumatic brain injury. J. Head Trauma Rehabil. 25, 72-80.
5. Sundström, T., Sollid, S., Wentzel-Larsen, T., and Wester, K. (2007). Head injury mortality in the nordic contries. J. Neurotrauma 24, 147-153.
6. Husson, E.C., Ribbers, G.M., Willemse-van Son, A.H., Verhagen, A.P., and Stam, H.J. (2010). Prognosis of six-month functioning after moderate to severe traumatic brain injury: a systematic review of prospective cohort studies. J. Rehabil. Med. 42, 425-436.
7. Stocchetti, N., Pagan, F., Calappi, E., Canavesi, K., Beretta, L., Citerio, G., Cormio, M., and Colombo, A. (2004). Inaccurate early assessment of neurological severity in head injury. J. Neurotrauma 21, 1131-1140.
8. Martins, E.T., Linhares, M.N., Sousa, D.S., Schroeder, H.K., Meinerz, J., Rigo, L.A., Bertotti, M.M., Gullo, J., Hohl, A., Dal-Pizzol, F., and Walz, R. (2009). Mortality in severe traumatic brain injury: a multivariated analysis of 748 Brazilian patients from Florianopolis City. J. Trauma 67, 85-90.
9. Marmarou, A., Lu, J., Butcher, I., McHugh, G.S., Murray, G.D., Steyerberg, E.W., Mushkudiani, N.A., Choi, S., and Maas, A.I. (2007). Prognostic value of the Glasgow Coma Scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an IMPACT analysis. J. Neurotrauma 24, 270-280.
10. Miller, J.D., Butterworth, J.F., Gudeman, S.K., Faulkner, J.E., Choi, S.C., Selhorst, J.B., Harbison, J.W., Lutz, H.A., Young, H.F., and Becker, D.P. (1981). Further experience in the management of severe head injury. J. Neurosurg. 54, 289-299.
11. Hukkelhoven, C.W., Steyerberg, E.W., Rampen, A.J., Farace, E., Habbema, J.D., Marshall, L.F., Murray, G.D., and Maas, A.I. (2003). Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J. Neurosurg. 99, 666-673.
12. Mushkudiani, N.A., Engel, D.C., Steyerberg, E.W., Butcher, I., Lu, J., Marmarou, A., Slieker, F., McHugh, G.S., Murray, G.D., and Maas, A.I. (2007). Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT study. J. Neurotrauma 24, 259-269.
13. Vos, P.E., Jacobs, B., Andriessen, T.M., Lamers, K.J., Borm, G.F., Beems, T., Edwards, M., Rosmalen, C.F., and Vissers, J.L. (2010). GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 75:1786-1793.
14. Winchell, R.J., Simons, R.K., and Hoyt, D.B. (1996). Transient systolic hypotension. A serious problem in the management of head injury. Arch. Surg. 131, 533-539.
15. Chesnut, R.M., Marshall, L.F., Klauber, M.R., Blunt, B.A., Baldwin, N., Eisenberg, H.M., Jane, J.A., Marmarou, A., and Foulkes, M.A. (1993). The role of secondary brain injury in determining outcome from severe head injury. J. Trauma 34:216-222.
16. Marshall, L.F., Marshall, S.B., Klauber, M.R., Clark, M.V., Eisenberg, H.M., Jane, J.A., Luerssen, T.G., Marmarou, A., and Foulkes, M.A. (1991). A new classification of head-injury based on computerizedtomography. J. Neurosurg. 75, S14-S20.
17. Maas, A.I., Steyerberg, E.W., Butcher, I., Dammers, R., Lu, J., Marmarou, A., Mushkudiani, N.A., McHugh, G.S., and Murray, G.D. (2007). Prognostic value of computerized tomography scan characteristics in traumatic brain injury: results from the IMPACT study. J. Neurotrauma 24, 303-314
18. Nelson, D.W., Nystrom, H., MacCallum, R.M., Thornquist, B., Lilja, A., Bellander, B.M., Rudehill, A., Wanecek, M., and Weitzberg, E. (2010). Extended analysis of early computed tomography scans of traumatic brain injured patients and relations to outcome. J. Neurotrauma 27, 51-64.
19. Van Beek, J.G., Mushkudiani, N.A., Steyerberg, E.W., Butcher, I., McHugh, J. Lu, G.S., Marmarou, A., Murray, G.D., and Maas, A.I. (2007). Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT study. J. Neurotrauma 24, 315-328.
20. Roozenbeek, B., Chiu, Y.L., Lingsma, H., Gerber, L.M., Steyerberg, E.W., Ghajar, J., and Maas, A. (2012). Predicting 14-day mortality after severe traumatic brain injury: application of the IMPACT models in the Brain Trauma Foundation TBI-trac-New York State database. J. Neurotrauma 29,1306-1312.
21. Murray, G.D., Butcher, I., McHugh, G.S., Lu, J., Mushkudiani, N.A., Maas, A.I., Marmarou, A., and Steyerberg, E.W. (2007). Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J. Neurotrauma 24, 329-337.
22. Murillo-Cabezas, F., Munoz-Sanchez, M.A., Rincon-Ferrari, M.D., Martin-Rodriguez, J.F., Amaya-Villar, R., Garcia-Gomez, S., and Leon-Carrion, J. (2010). The prognostic value of the temporal course of S100beta protein in post-acute severe brain injury: A prospective and observational study. Brain Inj. 24, 609-619.
23. Raabe, A.,Grolms, C., Sorge,O., Zimmermann, M., and Seifert, V. (1999). Serum S-100B protein in severe head injury. Neurosurgery 45, 477-483.
24. Herrmann, M., Jost, S., Kutz, S., Ebert, A.D., Kratz, T., Wunderlich, M.T., and Synowitz, H. (2000). Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J. Neurotrauma 17, 113-122.
25. Pelinka, L.E., Toegel, E., Mauritz, W., and Redl, H. (2003). Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 19, 195-200.
26. Savola, O., Pyhtinen, J., Leino, T.K., Siitonen, S., Niemela, O., and Hillbom, M. (2004). Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J. Trauma 56:1229-1234.
27. Korfias, S., Stranjalis, G., Boviatsis, E., Psachoulia, C., Jullien, G., Gregson, B., Mendelow, A.D., and Sakas, D.E. (2007). Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med 33, 255-260.
28. Gonzclez-Mao, M.C., Reparaz-Andrade, A., Del Campo-Perez, V., Alvarez-Garcia, E., Vara-Perez, C., and Andrade-Olivie, M.A. (2011). Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h. Clin Lab 57, 587-597.
29. Jonsson, H., Johnsson, P., Hoglund, P., Alling, C., and Blomquist, S. (2000). Elimination of S100B and renal function after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 14, 698-701.
30. Ghanem, G., Loir, B., Morandini, R., Sales, F., Lienard, D., Eggermont, A., and Lejeune, F. (2001). On the release and half-life of S100B protein in the peripheral blood of melanoma patients. Int. J. Cancer 94, 586-590.
31. Bellander, B.M., Olafsson, I.H., Ghatan, P.H., Bro Skejo, H.P., Hansson, L.O., Wanecek, M., and Svensson, M.A. (2011). Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B. Acta Neurochir. (Wien) 153, 90-100.
32. Haimoto, H., Hosoda, S., and Kato, K. (1987). Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab. Invest. 57, 489-498.
33. Herrmann, M., Curio, N., Jost, S., Wunderlich, M.T., Synowitz, H., and Wallesch, C.W. (1999). Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor. Neurol. Neurosci. 14, 109-114.
34. Woertgen, C., Rothoerl, R.D., Holzschuh, M., Metz, C., and Brawanski, A. (1997). Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir. (Wien) 139:1161-1165.
35. Kovesdi, E., Luckl, J., Bukovics, P., Farkas, O., Pal, J., Czeiter, E., Szellar, D., Doczi, T., Komoly, S., and Buki, A. (2010). Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir. 152, 1-17.
36. Honda, M., Tsuruta, R., Kaneko, T., Kasaoka, S., Yagi, T., Todani, M., Fujita, M., Izumi, T., and Maekawa, T. (2010). Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J. Trauma 69, 104-109.
37. Romner, B., Ingebrigtsen, T., Kongstad, P., and Borgesen, S.E. (2000). Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J. Neurotrauma 17, 641-647.
38. Raabe, A., Kopetsch, O., Woszczyk, A., Lang, J., Gerlach, R., Zimmermann, M., and Seifert, V. (2003). Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor. Neurol. Neurosci. 21,159-169.
39. Jackson, R.G., Samra, G.S., Radcliffe, J., Clark, G.H., and Price, C.P. (2000). The early fall in levels of S-100 beta in traumatic brain injury. Clin. Chem. Lab. Med. 38, 1165-1167.
40. Petzold, A., Green, A.J., Keir, G., Fairley, S., Kitchen, N., Smith, M., and Thompson, E.J. (2002). Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study. Crit. Care Med. 30, 2705-2710.
41. Woertgen, C., Rothoerl, R.D., and Brawanski, A. (2002). Early S-100B serum level correlates to quality of life in patients after severe head injury. Brain Inj. 16, 807-816.
42. Watt, S.E., Shores, E.A., Baguley, I.J., Dorsch, N., and Fearnside, M.R. (2006). Protein S-100 and neuropsychological functioning following severe traumatic brain injury. Brain Inj. 20, 1007-1017.
43. Acker, J.E., Ali, J., Aprahamian, C., Bell, R.M., Boyle, D.E., Collicott, P.E., Cooper, A., Doto, F.X., George, J.H., Hawkins, M.L., Hughes, I.K., Hunt, R.C., Jurkovich, G.J., Kaufmann, C.R., Kortbeek, J.B., Krantz, B.E., Krohmer, J.R., Leland, D.G., Marion, D.W., Metz, P.S., Narayan, R.K., Nichols, J.B., Olson, F.C., Parks, S.N., Poole, G.V., Ramenofsky, M.L., Rinker, C.F., Ruiz Speare, J.O., Simmonds, R.C., Timberlake, G.A., and Weigelt, J.A. (2004). Advanced Trauma Life Support for Doctors-ATLS, 7th ed. American College of Surgeons Committee on Trauma: Chicago.
44. Jennett, B., and Bond, M. (1975). Assessment of outcome after severe brain damage. Lancet 1:480-484.
45. Raabe, A., Menon, D.K., Gupta, S., Czosnyka, M., and Pickard, J.D. (1998). Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study. J. Neurol. Neurosurg. Psychiatry 65, 930-932.
46. Mussack, T., Klauss, V., Ruppert, V., Gippner-Steppert, C., Biberthaler, P., Schiemann, U., Hoffmann, U., and Jochum, M. (2006). Rapid measurement of S-100B serum protein levels by Elecsys S100 immunoassay in patients undergoing carotid artery stenting or endarterectomy. Clin. Biochem. 39, 349-356.
47. Perel, P., Arango, M., Clayton, T., Edwards, P., Komolafe, E., Poccock, S., Roberts, I., Shakur, H., Steyerberg, E., and Yutthakasemsunt, S. (2008). Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ 336, 425-429.
48. McHugh, G.S., Butcher, I., Steyerberg, E.W., Lu, J., Mushkudiani, N., Marmarou, A., Maas, A.I., and Murray, G.D. (2007). Statistical approaches to the univariate prognostic analysis of the IMPACT database on traumatic brain injury. J. Neurotrauma 24, 251-258.
49. Balestreri, M., Czosnyka, M., Chatfield, D.A., Steiner, L.A., Schmidt, E.A., Smielewski, P., Matta, B., and Pickard, J.D. (2004). Predictive value of Glasgow Coma Scale after brain trauma: change in trend over the past ten years. J. Neurol. Neurosurg. Psychiatry 75, 161-162.
50. Kotwica, Z., and Brzezinski, J. (1993). Acute subdural haematoma in adults: an analysis of outcome in comatose patients. Acta Neurochir. (Wien) 121, 95-99.
51. Unden, J., Bellner, J., Astrand, R., and Romner, B. (2005). Serum S100B levels in patients with epidural haematomas. Br. J. Neurosurg. 19, 43-45.
52. Eisenberg, H.M., Gary, Jr., H.E., Aldrich, E.F., Saydjari, C., Turner, B., Foulkes, M.A., Jane, J.A., Marmarou, A., Marshall, L.F., and Young, H.F. (1990). Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J. Neurosurg. 73, 688-698.
53. Aminmansour, B., Ghorbani, A., Sharifi, D., Shemshaki, H., and Ahmadi, A. (2009). Cerebral vasospasm following traumatic subarachnoid hemorrhage. J. Res. Med. Sci. 14, 343-348.
54. Kakarieka, A. (1997). Review on traumatic subarachnoid hemorrhage. Neurol. Res. 19, 230-232.
55. Vergouwen, M.D., Vermeulen, M., and Roos, Y.B. (2006). Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review. Lancet Neurol. 5, 1029-1032.
56. Gennarelli, T.A., Champion, H.R., Copes, W.S., and Sacco, W.J. (1994). Comparison of mortality, morbidity, and severity of 59,713 head injured patients with 114,447 patients with extracranial injuries. J. Trauma 37, 962-968.
57. McMahon, C.G., Yates, D.W., Campbell, F.M., Hollis, S., and Woodford, M. (1999). Unexpected contribution of moderate traumatic brain injury to death after major trauma. J. Trauma 47, 891-895.
58. Lingsma, H.F., Roozenbeek, B., Steyerberg, E.W., Murray, G.D., and Maas, A.I. (2010). Early prognosis in traumatic brain injury: from prophecies to predictions. Lancet Neurol. 9, 543-554.
59. Sarrafzadeh, A.S., Peltonen, E.E., Kaisers, U., Kuchler, I., Lanksch, W.R., and Unterberg, A.W. (2001). Secondary insults in severe head injury-do multiply injured patients do worse? Crit. Care Med. 29,1116-1123.
60. Anderson, R.E., Hansson, L.O., Nilsson, O., Dijlai-Merzoug, R., and Settergren, G. (2001). High serum S100B levels for trauma patients without head injuries. Neurosurgery 48:1255-1260.
61. Romner, B., and Ingebrigtsen, T. (2001). High serum S100B levels for trauma patients without head injuries. Neurosurgery 49,1490-1493.
62. Unden, J., Bellner, J., Eneroth, M., Alling, C., Ingebrigtsen, T., and Romner, B. (2005). Raised serum S100B levels after acute bone fractures without cerebral injury. J. Trauma 58, 59-61.
63. Routsi, C., Stamataki, E., Nanas, S., Psachoulia, C., Stathopoulos, A., Koroneos, A. Zervou, M., Jullien, G., and Roussos, C. (2006). Increased levels of serum S100B protein in critically ill patients without brain injury. Shock 26, 20-24.
64. da Rocha, A.B., Schneider, R.F., de Freitas, G.R., Andre, C., Grivicich, I., Zanoni, C., Fossa, A., Gehrke, J.T., Pereira Jotz, G., Kaufmann, M., Simon, D., and Regner, A. (2006). Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. Clin. Chem. Lab. Med. 44, 1234-1242.
65. Pham, N., Fazio, V., Cucullo, L., Teng, Q., Biberthaler, P., Bazarian, J.J., and Janigro, D. (2010) Extracranial sources of S100B do not affect serum levels. PLoS One 5, pii: e12691.
66. Raabe, A., Grolms, C., Keller, M., Dohnert, J., Sorge, O., and Seifert, V. (1998). Correlation of computed tomography findi+ngs and serum brain damage markers following severe head injury. Acta Neurochir. (Wien) 140, 787-792.
67. Pelinka, L.E., Harada, N., Szalay, L., Jafarmadar, M., Redl, H., and Bahrami, S. (2004). Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock 21, 72-76.
68. Olivecrona, M., Rodling-Wahlstrom, M., Naredi, S., and Koskinen, L.O. (2009). S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy. J. Neurol. Neurosurg. Psychiatry 80, 1241-1247.
69. Muller, K., Townend, W., Biasca, N., Unden, J., Waterloo, K., Romner, B., and Ingebrigtsen, T. (2007). S100B serum level predicts computed tomography findings after minor head injury. J. Trauma 62, 1452-1456.
70. Unden, J., and Romner, B. (2010). Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: an evidence-based review and meta-analysis. J. Head Trauma Rehabil. 25, 228-240.
71. Bellander, B.M., Olafsson, I.H., Ghatan, P.H., Bro Skejo, H.P., Hansson, L.O., Wanecek, M., and Svensson, M.A. (2011). Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B. Acta Neurochir (Wien) 153, 90-100.
72. Raabe, A., Kopetsch, O., Woszczyk, A., Lang, J., Gerlach, R., Zimmermann, M., and Seifert, V. (2004). S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurol. Res. 26, 440-445.
73. Maas, A.I., Braakman, R., Schouten, H.J., Minderhoud, J.M., and van Zomeren, A.H. (1983). Agreement between physicians on assessment of outcome following severe head injury. J. Neurosurg. 58, 321-325.
74. Miller, K.J., Schwab, K.A., and Warden, D.L. (2005). Predictive value of an early Glasgow Outcome Scale score: 15-month score changes. J. Neurosurg. 103, 239-245.
75. Smit, L.H., Korse, C.M., and Bonfrer, J.M. (2005). Comparison of four different assays for determination of serum S-100B. Int. J. Biol. Markers 20, 34-42.
76. Müller, K., Elverland, A., Romner, B., Waterloo, K., Langbakk, B., Unden, J., and Ingebrigtsen, T. (2006). Analysis of protein S-100B in serum: a methodological study. Clin. Chem. Lab. Med. 44, 1111-1114.